These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3720527)

  • 21. OPRM1 gene variants modulate amphetamine-induced euphoria in humans.
    Dlugos AM; Hamidovic A; Hodgkinson C; Shen PH; Goldman D; Palmer AA; de Wit H
    Genes Brain Behav; 2011 Mar; 10(2):199-209. PubMed ID: 21029375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of tilidine for morphine-like subjective effects and euphoria.
    Jasinski DR; Preston KL
    Drug Alcohol Depend; 1986 Nov; 18(3):273-92. PubMed ID: 3803198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dextroamphetamine with morphine: respiratory effects.
    Bourke DL; Allen PD; Rosenberg M; Mendes RW; Karabelas AN
    J Clin Pharmacol; 1983 Jan; 23(1):65-70. PubMed ID: 6404951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abuse liability assessment of sibutramine, a novel weight control agent.
    Schuh LM; Schuster CR; Hopper JA; Mendel CM
    Psychopharmacology (Berl); 2000 Jan; 147(4):339-46. PubMed ID: 10672626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparing the subjective, psychomotor, and physiological effects of intravenous hydromorphone and morphine in healthy volunteers.
    Hill JL; Zacny JP
    Psychopharmacology (Berl); 2000 Sep; 152(1):31-9. PubMed ID: 11041313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of fenfluramine and amphetamine in man.
    Griffith JD; Nutt JG; Jasinski DR
    Clin Pharmacol Ther; 1975 Nov; 18(5 Pt 1):563-70. PubMed ID: 1102234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lithium: effects on subjective functioning and morphine-induced euphoria.
    Jasinski DR; Nutt JG; Haertzen CA; Griffith JD; Bunney WE
    Science; 1977 Feb; 195(4278):582-4. PubMed ID: 319532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of d-amphetamine, morphine, naloxone, and drug combinations on visual discrimination in rats.
    Andrews JS; Holtzman SG
    Psychopharmacology (Berl); 1988; 94(2):172-7. PubMed ID: 3127842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dextroamphetamine with morphine for the treatment of postoperative pain.
    Forrest WH; Brown BW; Brown CR; Defalque R; Gold M; Gordon HE; James KE; Katz J; Mahler DL; Schroff P; Teutsch G
    N Engl J Med; 1977 Mar; 296(13):712-5. PubMed ID: 320478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative abuse liability of sertraline, alprazolam, and dextroamphetamine in humans.
    Zawertailo LA; Busto U; Kaplan HL; Sellers EM
    J Clin Psychopharmacol; 1995 Apr; 15(2):117-24. PubMed ID: 7782484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of morphine alone and in combination with naloxone or d-amphetamine on shock-maintained behavior in the squirrel monkey.
    Byrd LD
    Psychopharmacology (Berl); 1976 Sep; 49(3):225-34. PubMed ID: 826938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterizing the subjective, psychomotor, and physiological effects of a hydrocodone combination product (Hycodan) in non-drug-abusing volunteers.
    Zacny JP
    Psychopharmacology (Berl); 2003 Jan; 165(2):146-56. PubMed ID: 12404072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of amphetamine on reactivity to emotional stimuli.
    Wardle MC; de Wit H
    Psychopharmacology (Berl); 2012 Mar; 220(1):143-53. PubMed ID: 21947316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Behavioral and subjective effects of d-amphetamine and modafinil in healthy adults.
    Makris AP; Rush CR; Frederich RC; Taylor AC; Kelly TH
    Exp Clin Psychopharmacol; 2007 Apr; 15(2):123-33. PubMed ID: 17469936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cocaine effects during D-amphetamine maintenance: a human laboratory analysis of safety, tolerability and efficacy.
    Rush CR; Stoops WW; Hays LR
    Drug Alcohol Depend; 2009 Jan; 99(1-3):261-71. PubMed ID: 18926645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. D-Amphetamine-induced hypothermia and hypermotility in rats: changes after systemic administration of beta-endorphin.
    Yehuda S; Zadina J; Kastin AJ; Coy DH
    Peptides; 1980; 1(2):179-85. PubMed ID: 7243618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human d-amphetamine drug discrimination: methamphetamine and hydromorphone.
    Lamb RJ; Henningfield JE
    J Exp Anal Behav; 1994 Mar; 61(2):169-80. PubMed ID: 7513346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new psychotropic agent. Psychological and physiological effects of 2,5-dimethoxy-4-ethyl amphetamine (DOET) in man.
    Snyder SH; Faillace LA; Weingartner H
    Arch Gen Psychiatry; 1969 Jul; 21(1):95-101. PubMed ID: 4389442
    [No Abstract]   [Full Text] [Related]  

  • 39. The behavioral effects of d-amphetamine alone and in combination with acute and chronic morphine treatments in rats.
    Lucot JB; McMillan DE; Leander JD
    J Pharmacol Exp Ther; 1979 Aug; 210(2):158-65. PubMed ID: 572418
    [No Abstract]   [Full Text] [Related]  

  • 40. Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction.
    Jasinski DR; Pevnick JS; Griffith JD
    Arch Gen Psychiatry; 1978 Apr; 35(4):501-16. PubMed ID: 215096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.